ANRO8:03 AMAlto Neuroscience Appoints Karuna Therapeutics Founder Andrew Miller, Ph.D. to Board of Directorsaltoneuroscience.com
ANRO8:27 AMAlto Neuroscience CEO Amit Etkin, M.D., Ph.D. Receives Columbia University Transformational Research Awardaltoneuroscience.com
ANRO7:03 AMAlto Neuroscience Reports First Quarter 2026 Financial Results and Recent Business Highlightsaltoneuroscience.com
ANRO4:05 PMAlto Neuroscience Announces Participation in Upcoming Investor Conferencesaltoneuroscience.com
ANRO8:03 AMAlto Neuroscience Initiates Phase 2b Trial of ALTO-207 in Treatment-Resistant DepressionTrial Start • Phase 2altoneuroscience.com
ANRO4:30 PMAlto Neuroscience Reports Topline Data from Phase 2 Proof-of-Concept Study of ALTO-101 and Highlights Pipeline AdvancementsTrial Results • Phase 2altoneuroscience.com
ANRO6:03 AMAlto Neuroscience Reports Full Year 2025 Financial Results and Recent Business Highlightsaltoneuroscience.com
ANRO8:03 AMAlto Neuroscience Announces Participation at the Stifel 2026 Virtual CNS Forumaltoneuroscience.com